IRulya Therapeutics Inc. (IRLA) Price Prediction & Forecast

$31.095

+1.894 (+6.09%)At close

Price Predictions

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

Should I Buy IRulya Therapeutics Inc. Stock?

IRulya Therapeutics Inc is not a good buy right now due to its significant financial losses and weak performance indicators. The stock is currently priced at 31.09, but it has a forward P/E of 0 and a negative EPS estimate of -0.8300 for the upcoming earnings report. Additionally, the company has reported a net income loss of -39,458,000 for Q4 2025, indicating ongoing financial struggles. The main risk is its declining current ratio, which has fallen to 0.53, suggesting potential liquidity issues.

IRLA stock price ended at $31.09 on Friday, after rising +6.09%

IRulya Therapeutics Inc. (IRLA) last closed at $31.0949993, gaining +6.09%. These facts feed the 1-day and 1-week IRLA price prediction above.

Forecast Drivers

IRulya Therapeutics Inc. (IRLA) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Seasonality

Negative

Bearish

Seasonality analysis for IRLA